Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1633–1656 of 6,918 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Autism Spectrum Disorder
Interventions: Magnetic Resonance Therapy (MRT)-Active, Magnetic Resonance Therapy (MRT)-Sham; Device
Lead sponsor: Wave Neuroscience; Industry
Eligibility: 4 Years to 12 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Newport Beach, California • Buford, Georgia

Conditions: Chronic Cough
Interventions: Acceptance and Commitment Therapy (ACT); Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cervical Cancer, Endometrial Cancer, Ovarian Epithelial Cancer, Ovarian Germ Cell Tumor, Uterine Sarcoma, Vulvar Cancer
Interventions: questionnaire administration, standard follow-up care, educational intervention; Other · Procedure
Lead sponsor: New Mexico Cancer Research Alliance; Other
Eligibility: 30 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Postpartum Hemorrhage
Interventions: Tranexamic Acid, Placebo; Normal Saline; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
Interventions: moxifloxacin hydrochloride, Placebo; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 120 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Anxiety, Intraoperative Hypertension, Cataract
Interventions: Music Intervention, Television Intervention; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Low Back Pain
Interventions: Mindfulness Based Therapy, Cognitive Behavioral Therapy; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years and older
Enrollment: 770 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 4
States / cities: Boston, Massachusetts • Hershey, Pennsylvania • Salt Lake City, Utah + 1 more

Conditions: Septic Shock
Interventions: Near-infrared spectroscopy assessment; Diagnostic Test
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism Spectrum Disorder
Interventions: Project Personality, Sharing Feelings Intervention; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: 11 Years to 16 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Acute Myeloid Leukemia
Interventions: Usual Care, Psychological intervention; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Exposure to Pollution, Inhalation of Ozone
Interventions: Ozone exposure, Diesel exhaust, Ozone18, Clean Air; Other
Lead sponsor: Environmental Protection Agency (EPA); Federal
Eligibility: 18 Years to 55 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Spinal Cord Injury
Interventions: Respiratory Muscle Training; Behavioral
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Hypertension
Interventions: Inspiratory muscle strength training; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 50 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Accidental Fall, Nurse's Role
Interventions: Virtual reality simulation app for caregiver education, online fall prevention education module; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Not listed
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Avon, Ohio • Mayfield Heights, Ohio

Conditions: Nausea, Vomiting, Satisfaction
Interventions: Acupressure Point P6 stimulator, Metoclopramide, Ondansetron; Device · Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Non-squamous NSCLC, HER2 Exon 20 Mutation
Interventions: Pyrotinib, Docetaxel; Drug
Lead sponsor: Jiangsu HengRui Medicine Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 11
States / cities: Orange, California • Sacramento, California • Whittier, California + 8 more

Conditions: Morbid Obesity, Noninvasive Ventilation, Deep Sedation
Interventions: High flow nasal cannula, Nasal Cannula; Device
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Resident Communication Skills Rated by Patients
Interventions: Communication Skills Curriculum; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 411 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Sleep Quality, Menopause
Interventions: Lotus Seed & Rice Germ Extract, Placebo; Dietary Supplement · Other
Lead sponsor: Nutraland USA, Inc.; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension
Interventions: Yogic practice, Conventional Exercise; Other
Lead sponsor: Long Island University; Other
Eligibility: 21 Years to 74 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Healthy
Interventions: 100 mg CNTO 3157, 300 mg CNTO 3157, 600 mg CNTO 3157, Placebo; Biological · Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Cypress, California

Conditions: Metabolic Syndrome, Obesity
Interventions: Single Bout of Exercise, Control Condition; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 40 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Gingivitis
Interventions: Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice, electric toothbrush, Cetylpyridinium Chloride (CPC), manual toothbrush; Drug · Device
Lead sponsor: Procter and Gamble; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Oral Mucositis, Stomatitis
Interventions: velafermin, placebo; Drug
Lead sponsor: CuraGen Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 33
States / cities: Little Rock, Arkansas • Berkley, California • La Jolla, California + 26 more

Search by objective public record fields.

A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism

Feasibility, Acceptability, and Safety Trial of Brief, Breath Control-Focused Acceptance and Commitment Therapy in Adults With Chronic Cough

Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors

Tranexamic Acid and Thromboelastography During Cesarean Delivery

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

The Effects of Music and Television on Intraoperative Hypertensive Events in Cataract Surgery

Strategies to Assist With Management of Pain

Near Infrared Spectroscopy (St02)

Promoting Resilience in Teens With ASD

Psychological Intervention Mobile App for Patients With AML

Epigenetic Effects of Diesel Exhaust and Ozone Exposure

Respiratory Motor Control and Blood Pressure Regulation After Spinal Cord Injury

Reduced Volume of Inspiratory Resistance Training

Virtual Reality Fall Education for Caregivers

Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite

Measuring the Impact of an Interactive Communication Skills Curriculum on Internal Medicine Residents

Effect of ZenRest™ Lotus Seed & Rice Germ Extract Blend on Sleep Quality in Menopausal Women

Effectiveness of Yoga on Ambulatory Blood Pressure in Patients With Pre- and Stage I Hypertension

A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants

Impact of Acute Exercise on Vascular Insulin Sensitivity in Metabolic Syndrome

A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis